Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
Covid-19 poses major challenges for developing and mass-producing vaccines and medicines in existing production facilities
10-Jun-2020 -
Siemens and Exyte join forces to offer end-to-end solutions for the biopharmaceutical industry by combining the digitalization expertise of Siemens with the innovation boost from Exyte.
Against the background of the current challenges associated with the Covid-19 pandemic, pharmaceutical ...
biologicals
cell therapeutics
coronaviruses
+4